Sharon Helene O'Neil, PhD

Clinical Associate Professor of Neurology and Pediatrics (Part-Time)

Image of Sharon Helene O’Neil, PhD
Is this your profile? Click to edit

Overview

Dr. O’Neil is board certified in clinical neuropsychology (ABPP-CN) and in pediatric neuropsychology (ABPdN). She is the director of the Neuropsychology Core of The Saban Research Institute at Children’s Hospital Los Angeles. Dr. O’Neil is involved in research focusing on the neuropsychological sequelae of brain cancer diagnoses and treatment, preterm birth, congenital heart disease, autism spectrum disorders, and sickle and non-sickle anemias. Additionally, she teaches and trains doctoral students in the provision of neuropsychological services.

Publications

  • Effects of disease modifying therapy on cognitive proficiency in pediatric-onset multiple sclerosis (POMS). Mult Scler Relat Disord. 2026 May; 109:107104.. View in PubMed
  • Decreased Gross Motor, Working Memory, and Adaptive Behavior in Children with Congenital Adrenal Hyperplasia. Horm Res Paediatr. 2026 Feb 16; 1.. View in PubMed
  • Adaptive, social, and repetitive behaviors in children with autism spectrum disorder and comorbid amblyopia and/or strabismus. J AAPOS. 2026 Feb; 30(1):104734.. View in PubMed
  • Assessment of neurocognitive functioning in sickle cell disease and thalassaemia and the association with silent cerebral infarcts, cerebral haemodynamics and oxygen metabolism. Br J Haematol. 2025 Aug; 207(2):561-570.. View in PubMed
  • Adaptive functioning and relationship to visual behavior in children with cerebral/cortical visual impairment. J AAPOS. 2025 02; 29(1):104107.. View in PubMed
  • Dose-dependent cranial irradiation associations with brain structures and neuropsychological outcomes in children with posterior fossa brain tumors. Brain Behav. 2024 Sep; 14(9):e70019.. View in PubMed
  • Tract-specific analysis and neurocognitive functioning in sickle cell patients without history of overt stroke. Brain Behav. 2021 03; 11(3):e01978.. View in PubMed
  • Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on “Head Start” III: a multi-institutional, prospective clinical trial. Neuro Oncol. 2020 12 18; 22(12):1862-1872.. View in PubMed
  • Brain biomarkers and neuropsychological outcomes of pediatric posterior fossa brain tumor survivors treated with surgical resection with or without adjuvant chemotherapy. Pediatr Blood Cancer. 2021 02; 68(2):e28817.. View in PubMed
  • Neuropsychological outcomes on Head Start III: a prospective, multi-institutional clinical trial for young children diagnosed with malignant brain tumors. Neurooncol Pract. 2020 Jun; 7(3):329-337.. View in PubMed